Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics

Sam Banister is a medicinal chemist and co-founder of Psylo.  Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic medicines to treat mental illness.   

Sam is here to help us understand how new chemical entities are reshaping the psychedelic field; how novel psychedelic molecules are made,  and how new chemical entities are going to play a dominant role in the future of psychedelic medicine.  

Make sure to subscribe to the show!  

Follow Brom on twitter: https://twitter.com/therealbrom

Follow Sam on twitter: https://twitter.com/samuel_b_phd

Brom's VC Fund:  https://www.empath.vc

Highlighted Timestamps:  

06:12 - Are next generation psychedelics taking over in 10 years?  

16:10 - What is the process like for creating a new chemical entities?  

50:39 - Psychedelics vs Cannabis: New drug discoveries